Are there dissociable roles of the mesostriatal and mesolimbocortical dopamine systems on temporal information processing in humans?

Neuropsychobiology

Volumn 35, Issue 1, 1997, Pages 36-45

  Rammsayer, Thomas H ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Basal ganglia; Dopamine; Human subjects; Time perception

Indexed keywords

DOPAMINE; DOPAMINE 2 RECEPTOR; HALOPERIDOL; REMOXIPRIDE; SULPIRIDE;

ADULT; AROUSAL; ARTICLE; BASAL GANGLION; COGNITION; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; HUMAN; HUMAN EXPERIMENT; INFORMATION PROCESSING; MALE; MOTOR ACTIVITY; NEUROANATOMY; NORMAL HUMAN; PRIORITY JOURNAL; TIME PERCEPTION; VELOCITY;

ADULT; AROUSAL; ATTENTION; BASAL GANGLIA; CEREBRAL CORTEX; CORPUS STRIATUM; DOPAMINE; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FLICKER FUSION; HALOPERIDOL; HUMANS; LIMBIC SYSTEM; MALE; MESENCEPHALON; NEURAL PATHWAYS; PSYCHOMOTOR PERFORMANCE; REACTION TIME; RECEPTORS, DOPAMINE D2; REMOXIPRIDE; SENSORY THRESHOLDS; SULPIRIDE; TIME PERCEPTION;

EID: 0031014719     PISSN: 0302282X     EISSN: 14230224     Source Type: Journal    
DOI: 10.1159/000119328     Document Type: Article

References (91)

1. Russel RW: Drugs as tools for research in neu-ropsychobiology: A historical perspective. Neuropsychobiology 1987; 18:134-143.
2. Janke W: Pharmacopsychology as a basic and applied science. Neuropsychobiology 1983:10: 48.
3. Fraisse P: Perception and estimation of time. Annu Rev Psychol 1984:35:1-36.
4. Rammsayer T: Die Wahrnehmung kurzer Zeitdauern. Münster, Waxmann. 1992.
5. Rammsayer TH, Lima SD: Duration discrimination of filled and empty auditory intervals: Cognitive and perceptual factors. Perception and Psychophysics 1991:50:565-574.
6. Rammsayer TH: Temporal information processing and memory: in Ward LM (ed): Rechner Day 94. Proc 10th Annu Meet int Soc Psychophvs. Vancouver. The International Society for Psychophysics, 1994. pp 48-53.
7. Frankenhaeuser M: Estimation of Time. Uppsala, Almqvist & Wiksells, 1959.
8. Omstein RE: On the Experience of Time. Harmondsworth. Penguin. 1969.
9. Burnside W: Judgment of short time intervals while performing mathematical tasks. Percept Psychophys 1971:9:404-406.
10. Block RA, Reed MA: Remembered duration: evidence for a contextual change hypothesis. J Exp Psychol Learn Mem 1978:4:656-665.
11. Michon JA: The compleat time experiencer; in Michon JA. Jackson JL (eds): Time, Mind, and Behavior. Berlin. Springer, 1985, pp 21-52.
12. Abel SM: Discrimination of temporal gaps. J Acoust Soc Am 1972:52:519-524.
13. Abel SM: Duration discrimination of noise and tone bursts. J Acousl Soc Am 1972:52:1219-1223.
14. Allan LG, Krislofferson AB, Wiens EW: Duration discrimination of brief light flashes. Percept Psychophys 1971:9:327-334.
15. Allan LG, Kristofferson AB: Psychophysical theories of duration discrimination. Percept Psychophys 1974;16:26-34.
16. Creelman CD: Human discrimination of auditory duration. J Acoust Soc Am 1962:34:582-593.
17. Getty DJ: Discrimination of short temporal intervals: a comparison of two models. Percept Psychophys 1975:16:1-8.
18. Rammsayer TH: Effects of practice and signal energy' on duration discrimination of brief auditory intervals. Percept Psychophys 1994:55: 454-464.
19. Church RM: Properties of the internal clock. Ann NY Acad Sei 1984:423:566-582.
20. Fetterman JG, Killeen PR: Time discrimination in Columbia liria and llomo sapiens. J Exp Psychol Anim Behav Proc 1992; 18:80-94.
21. Meck WH: Selective adjustment of the speed of internal clock and memory processes. J Exp Psychol Anim Behav Proc 1983:9:171-201.
22. Allan LG: News on the internal clock. Int J Psychol 1992;27:2L
23. Maricq AV, Church RM: The differential effects of haloperidol and mcthamphetaminc on time estimation in the rat. Psychopharmacology 1983:79:10-15.
24. Maricq AV. Roberts S, Church RM: Methamphetamine and time estimation. J Exp Psychol Anim Behav Proc 1981:7:18-30.
25. Rammsayer T: Is there a common dopaminergic basis of time perception and reaction time? Neuropsychobiology 1989;21; 37-42.
26. Carboni E, Imperato A, Perezzani L, DiChiara G: Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus ac-cumbens of freely moving rats. Neuroscience 1989:28:653-661.
27. Hcikkila RE, Orlansky H. Mytilineou C, Cohen G: Amphetamine: Evaluation of d- and l-isomers as releasing agents and uptake inhibitors for 'H-dopamine and 'H-norepinephrinc in slices of rat neostriatum and cerebral cortex. J Pharmacol ExpTher 1975:194:47-56.
28. 2+ dependence of the amphetamine, nomifensine, and Lu 19-005 effect on in vivo dopamine transmission. Eur J Pharmacol 1989:166:261-269.
29. Rammsayer T, Vogel WH: Pharmacologic properties of the internal clock underlying time perception in humans. Neuropsychobiology 1992:26:71-80.
30. DeQualtro V. Sjoerdsma A: Catecholamine turnover in normotensive and hypertensive man: Effects of antiadrenergic drugs. J Clin Invest 1968;47:2359-2373.
31. Carlsson A, Roos BE, Walinder J, Skott A: Further studies on the mechanism of antipsychotic action: potentiation by a-mcthyltyrosine of thioridazine effects in chronic schizophrenics. J Neural Transm 1973:34:125-132.
32. Laverty R: Catecholamines: Role in health and disease. Drugs 1978:16:418-440.
33. Moore KE: The actions of amphetamine on neurotransmitters: A brief review. Biol Psychiatry 1977:12:451-462.
34. Gerlach J, Casey DE: Rcmoxipride. a new selective D2 antagonist, and haloperidol in ce-bus monkeys. Prog Neuropsychopharmacol Biol Psychiatry 1990:14:103-112.
35. Mercu GP, Casu M, Gessa GL: (-)-Sulpiride activates the firing rate and tyrosine hydroxylase activity of dopaminergic neurons in un-anesthctized rats. Brain Res 1983:264:105-110.
36. Tagliamontc A, de Montis MG. Olianas MC, Vargiu L. Corsini GU. Gessa GL: Selective increase of brain dopamine synthesis by sulpiride. J Neurochem 1975:24:707-710.
37. Kaembach C: Simple adaptive testing with the weighted up-down method. Percept Psychophys 1991;49:227-229.
38. Rammsayer TH: An experimental comparison of the weighted up-down method and the transformed up-down method. Bull Psychonom Soc 1992;30:425-427.
39. Hincmarch I: Critical flicker fusion frequency (CFF): The effects of psychotropic compounds. Pharmacopsychiatry 1982:15(suppl 1):44-48.
40. Smith JM, Misiak H: Critical tlicker frequency (CFF) and psychotropic drugs in normal human subjects. Psychopharmacology 1976:47: 175-182.
41. Frewcr IJ, Hindmarch I: The effect of time of day, age, and anxiety on a choice reaction task: in Hindmarch I. Aufdembrinke B. Ott H (eds): Psychopharmacology and Reaction Time. Chichester, Wiley. 1988. pp 103-114.
42. Halliday R, Callaway E, Naylor H, Gratzinger P, Prael R: The effects of stimulant drugs on information processing in elderly adults. J Gerontol 1986:41:748-757.
43. Peroutka SJ, Snyder SH: Relationship of neuroleptic drug effects at brain dopamine, serotonin. adrenergic, and histamine receptors to clinical potency. Am J Psychiatry 1980:137: 1518-1522.
44. Forsman AO: Haloperidol: A new profile? Proc R Soc Med 1976:69(suppl 1):9-13.
45. Öhman R, Forsman A, Larsson M: Prolactin response to haloperidol after a single oral dose and during prolonged administration. Curr TherRes 1980:27:137-143.
46. Ögren SO, Hall H, Kohler C, Magnusson O, Lindbom LO, Angeby K, Florvall L: Remoxi-pride, a new potential antipsychotic compound with selective antidopaminergic actions in the brain. Eur J Pharmacol 1984:102:459-474.
47. Köhler C, Hall H, Magnusson O, Lewander T, Gustafsson K: Biochemical pharmacology of the atypical neuroleptic remoxipride. Acta Psychiatr Scand 1990;82(suppl):27-36.
48. Bahr v C, Movin G, Yisak WA, Jostell KG, Wid man M: Clinical pharmacokinetics of re-moxipride. Acta Psychiatr Scand 1990:82 (suppl):41-44.
49. Soni SD, Tench D, Ashwood TJ, Movin G: Pharmacokinetics of an oral controlled release formulation of remoxipride: A double-blind, crossover comparison with conventional formulation in chronic schizophrenics. Acta Psychiatr Scand 1990;82(suppl):45-47.
50. Lewander T, Westerbergh SE, Morrison D: Clinical profile of remoxipride- a combined analysis of a comparative double-blind multi-centre trial programme. Acta Psychiatr Scand 1990;82(suppl):92-98.
51. Tricklebank MD, Bristow IJ, Hutson PH: Alternative approaches to the discovery of novel antipsychotic agents. Fortschr Arzneimittel-forsch 1992:38:299-336.
52. Serra G, Forgione A, d'Aquila PS, Collu M, Fralta W, Gessa GL: Possible mechanisms of antidepressant effect of L-sulpiride. Clin Neu-ropharmacol 1990; 13(suppl 1):S76-S83.
53. Bressolle F, Bres J, Faure-Jeantis A: Absolute bioavailability, rate of absorption, and dose proportionality of sulpiride in humans. J Pharm Sei 1992;81:26-32.
54. Kirk RE: Experimental Design: Procedures for the Behavioral Sciences. Belmont. Wadsworth Publishing Company. 1982.
55. While FJ. Wang RY: Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons. Science 1983: 221:1054-1057.
56. Brücke T, Roth J, Podreka Strobl R, Wenger S, Asenbaum S: Striatal dopamine D2-reeeptor blockade by typical and atypical neuroleptics. Lancet 1992:339:497.
57. Seeman P: Atypical neuroleptics: role of multiple receptors, endogenous dopamine, and receptor linkage. Acta Psychiatrica Scandinavica, 1990;82(suppl): 14-20.
58. Walinder J, Ilolm AC: Experiences of longterm treatment with remoxipride: Efficacy and tolerability. Acta Psychiatr Stand 1990: 82(suppl):158-163.
59. Crow TJ, Deakin JFW, Longden A: The nucleus accumbens - possible site of antipsychotic action of neuroleptic drugs? Psychol Med 1977;7:213-221.
60. Seeman P: Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1987;1:133-152.
61. Kecle SW, Pokorny RA, Corcos DM, Ivry R: Do perception and motor production share common timing mechanisms: A correlational analysis. Acta Psychol 1985:60:173-191.
62. Prinz W: Ideo-motor action: in Heuer H. Sanders AF (eds): Perspectives on Perception and Action. Hillsdale. Erlbaum. 1987, pp47-76.
63. Klapp ST: Temporal compatibility in dual motor tasks II: Simultaneous articulation and hand movements. Mem Cogn 1981:9:398-401.
64. Peters M: Simultaneous performance of two motor activities: The factor of timing. Neuro-psychologia 1977:15:461-465.
65. Homykiewicz O: Neurochemistry of parkinsonism: in Lajtha A (ed): Handbook of Neurochemistry. New York. Plenum. 1972, vol 7. pp 465-501.
66. Rammsayer T, Classen W: Vergleich der Zeitdauerdiskriminationsleistung schizophrener Patienten und Patienten mit Parkinsonsyndrom. 32nd Congr Exp Psychol, Regensburg. April 9-12.1990.
67. Artieda J, Pastor MA, Lacruz F, Obeso JA: Temporal discrimination is abnormal in Parkinson's disease. Brain 1992; 115:199-210.
68. Amalric M, Koob GF: Depletion of dopamine in the caudate nucleus but not in nucleus accumbens impairs reaction-time performance in rat. J Neurosci 1987;7:2129-2134.
69. Apicella P, Legallet E, Nicoullon A, Trouehe E: Quantitative behavioral study of the acute and long-term effects of two-stage bilateral 6-OHDA-induccd lesions of the nigrostriatal dopaminergic system in monkeys. Behav Neurosci 1995:109:329-341.
70. Carli M, Jones GH. Robbins TW: Effects of unilateral dopamine depletion from the dorsal and ventral striatum on visual neglect in the rat: A neural and behavioural analysis. Neuroscience 1989:29:309-327.
71. Salamoile JD, Kurth PA, McCullough LD, So-kolowski JD, Cousins MS: The role of brain dopamine in response initiation: Effects of haloperidol and regionally specific dopamine depletions on the local rate of instrumental responding. Brain Res 1993:628:218-226.
72. McGrath JE, Kelly JR: Time and Human Interaction. New York, Guilford Press. 1986.
73. Fortin C, Rousseau R: Time estimation as an index of processing demand in memory search. Percept Psychophys 1987:42:377-382.
74. Fortin C, Rousseau R, Bourque P, Kirouac E: Time estimation and concurrent nontemporal processing: Specific interference from short-term-memory demands. Percept Psychophys 1993:53:536-548.
75. Curran HV, Birch B: Differentiating the sedative, psychomotor and amnesic effects of benzodiazepines: A study with midazolam and the benzodiazepine antagonist, flumazenil. Psy-chopharmaeology 1991:103:519-523.
76. File SE, Skelly AM, Girdler NM: Midazolam-induced retrieval impairments revealed by the use of flumazenil: a study in surgical dental patients. J Psychopharmacol 1992:61:81-87.
77. Hennessy MJ, Kirkby KC, Montgomery IM: Comparison of the amnesic effects of midazolam and diazepam. Psychopharmacology 1991: 103:545-550.
78. Mattila MJ, Mattila ME, Konno K, Saarialho-Kere U: Objective and subjective effects of remoxipride. alone and in combination with ethanol or diazepam, on performance in healthy subjects. J Psychopharmacol 1988:2: 138-149.
79. Rammsayer T: Pharmakologische Beeinflussung der Zeitwahmehmung. Regensburg. Rüderer, 1987.
80. Squitieri G, Cervone A, Agnoli A: A study on short-term memory in man. Interactions with nooanaleptic and nootropic drugs; in Antonclli F (ed): Proc 3rd Congr Int Coll Psychosom Med. Rome, Pozzi, 1977. pp 742-751.
81. Goldstone S, Nürnberg HG, Lhamon WT: Effects of trifluoperazine, chlorpromazine. and haloperidol upon temporal information processing by schizophrenic patients. Psychophar-macology 1979:65:119-124.
82. Goldstone S, Lhamon WT: The effects of haloperidol upon temporal information processing by patients with Tourctte's syndrome. Psycho-pharmacology 1976:50:7-10.
83. Brozoski TJ, Brown RM, Rosvold HE, Goldman P: Cognitive deficit caused by regional depletion of dopamine in prcfrontal cortex of rhesus monkey. Science 1979:205:929-931.
84. Luciana M, Depue RA, Arbisi P, Leon A: Facilitation of working memory in humans by a D2 dopamine receptor agonist. J Cogn Neurosci 1992:4:58-68.
85. Park S, Holzman PS: Association of working memory deficit and eye tracking dysfunction in schizophrenia. Schizophr Res 1993:11:55-61.
86. Sawaguchi T, Matsumura M, Kubota K: Dopamine enhances the neuronal activity of spatial short-term memory task in the primate pre-frontal cortex. Neurosci Res 1988;5:465-473.
87. Sawaguchi T, Matsumura M, Kubota K: Effects of dopamine antagonists on neuronal activity related to a delayed response task in monkey prefrontal cortex. J Neurophysiol 1990:63:1401-1412.
88. Cassano GB, Castrogiovanni P, Conti L, Bonollo L: Sulpiride versus haloperidol in schizophrenia: A double blind comparative trial. Curr Ther Res 1975; 17:189-201.
89. Corsini GU, del Zompo M, Melis GB, Mangoni A, Gessa GL: (-)-Sulpiride as a specific antagonist of ‘low dose’ effects of apomorphine in man: in Spano PF. Trabucchi M, Corsini U. Gessa GL (eds): Sulpiride and Other Benzamides. New York. Raven Press. 1979. pp 225-267.
90. Serra G, van Ree JM, de Wied D: Influence of classical and atypical neuroleptics on apomorphine induced behavioural changes and on extinction of a conditioned avoidance response. J Pharm Pharmacol 1983:35:255-257.
91. Crecse I: Biochemical properties of CNS dopamine receptors; in Meitzer HY (ed): Psycho-pharmacologv: The Third Generation of Progress. New York. Raven Press. 1987, pp 257-264.